Beth E. Devine
EducationPhD University of Washington, 2008 (Health Services Research)
MBA University of San Francisco, 1999 (Business Admin Masters)
PharmD University of The Pacific, 1978
BPHARM University of The Pacific, 1975 (Pharmacy)
Contact Infoemail: firstname.lastname@example.org
Pharmaceutical Outcomes Research and Policy Program
University of Washington
Seattle, WA 98195-7620
campus box: 357630
Beth Devine is a health services research scientist and health economist. She studies medication safety, specifically pharmacogenomic biomarker-guided medication use and adverse drug events using real world evidence from electronic health records. Her work draws from the disciplines of patient-centered outcomes research and clinical informatics; she employs methods from epidemiology, biostatistics, and decision analysis. Her second area of emphasis is evidence synthesis, network meta-analysis and network meta-analysis, wherein she teaches and mentors graduate students. Dr. Devine is an elected member of the Society for Research Synthesis Methods and served on the ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Task Force that developed guidelines to conduct network meta-analyses.
Devine EB, Alfonso-Cristancho R, Yanez ND, Edwards TC, Patrick DL, Armstrong CA, Devlin A, Symons RG, Meissner MH, Derrick EL, Lavallee DC, Kessler LG, Flum DR; Comparative Effectiveness Research Translation Network (CERTAIN) Collaborative.. Effectiveness of a Medical vs Revascularization Intervention for Intermittent Leg Claudication Based on Patient-Reported Outcomes. JAMA Surg. 2016 Oct 19;151(10):e162024. doi: 10.1001/jamasurg.2016.2024. PMID: 27760274
Chavez LJ, Liu CF, Tefft N, Hebert PL, Devine B, Bradley KA. The Association Between Unhealthy Alcohol Use and Acute Care Expenditures in the 30 Days Following Hospital Discharge Among Older Veterans Affairs Patients with a Medical Condition. J Behav Health Serv Res. 2016 Sep 1. [Epub ahead of print] PMID: 27585803
Wheat CL, Clark-Snustad K, Devine B, Grembowski D, Thornton TA, Ko CW. Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2016;2016:1632439. doi: 10.1155/2016/1632439. Epub 2016 May 16. Review. PMID: 27293427 PMCID: PMC4884856
Devine EB. The Value of Computerized Provider Order Entry: Is It Time for the Debate to Be Over? Jt Comm J Qual Patient Saf. 2015 Aug;41(8):339-40. PMID: 26215522
Comparative effectiveness research is a growing field that aims to generate evidence to improve health care decisions for patients and providers. It examines the benefits and risks of different medical or healthcare interventions, including drugs and medical technology. The results of these comparison studies are used by medical professionals to make better informed healthcare decisions and thereby improve patient care.